Comparison of the Effects of Bevacizumab Before vs After Pattern Panretinal Photocoagulation
NCT ID: NCT00804206
Last Updated: 2024-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE4
15 participants
INTERVENTIONAL
2008-07-31
2008-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy
NCT00347698
Intravitreal Bevacizumab for Diabetic Retinopathy
NCT00600262
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
NCT00347399
Intravitreal Bevacizumab for Age-Related Macular Degeneration
NCT00347165
Avastin for Post-photocoagulation Macular Edema
NCT00801866
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Bevacizumab before panretinal photocoagulation.
bevacizumab
Intravitreal bevacizumab before panretinal photocoagulation
Group B
Bevacizumab after panretinal photocoagulation
bevacizumab
Intravitreal Bevacizumab after panretinal photocoagulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bevacizumab
Intravitreal bevacizumab before panretinal photocoagulation
bevacizumab
Intravitreal Bevacizumab after panretinal photocoagulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with macular edema
Exclusion Criteria
* patients with ocular surgeries
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asociación para Evitar la Ceguera en México
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asociación para Evitar la Ceguera en México
México, , Mexico
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
APEC-040
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.